As cancer develops, at least two cell processes are disrupted — cell growth is promoted, and cell death inhibited. It seems that mutated versions of the notorious cancer-promoting protein MYC can accomplish both at once.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hemann, M. T. et al. Nature 436, 807–811 (2005).
Chang, D. W., Claassen, G. F., Hann, S. R. & Cole, M. D. Mol. Cell. Biol. 20, 4309–4319 (2000).
Egle, A., Harris, A. W., Bouillet, P. & Cory, S. Proc. Natl Acad. Sci. USA 101, 6164–6169 (2004).
Wu, S. et al. Oncogene 22, 351–360 (2003).
Seoane, J., Le, H. V. & Massagué, J. Nature 419, 729–734 (2002).
Collins, N. L. et al. Mol. Cell. Biol. 25, 5282–5291 (2005).
Schmitt, C. A. et al. Cell 109, 335–346 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berns, A. Two in one. Nature 436, 787–789 (2005). https://doi.org/10.1038/436787a
Published:
Issue Date:
DOI: https://doi.org/10.1038/436787a
